High-dose corticosteroid therapy in COVID-19: the RECOVERY trial
- PMID: 38582560
- DOI: 10.1016/S0140-6736(23)02880-5
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial
Comment in
-
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.Lancet. 2024 Apr 6;403(10434):1339-1340. doi: 10.1016/S0140-6736(23)02879-9. Lancet. 2024. PMID: 38582564 No abstract available.
Comment on
-
Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.Lancet. 2023 Jun 17;401(10393):2025. doi: 10.1016/S0140-6736(23)01175-3. Epub 2023 Jun 9. Lancet. 2023. Retracted and republished in: Lancet. 2023 Jun 17;401(10393):e21-e33. doi: 10.1016/S0140-6736(23)00810-3. PMID: 37307841 Free PMC article. Retracted and republished. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical